Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
NSF
Acute Kidney Injury
MRI
Drugdevelopment
Health Care
Oncology
Orphan drug
Contrast Media
Chronic Kidney Disease
Contrast Induced Nephropathy
Medical
Radiology
Date founded
2000
Funding rounds raised
Total raised
$24M
from 2 investors over 2 rounds
A
Ascelia Pharma AB raised $24M on March 17, 2021
Investors: HealthInvest Partners and Sunstone Life Science Ventures